Men's Vitality Supplements: What The Evidence Supports

Any honest guide to this aisle has to start by naming what a supplement is competing against, and in this category the two strongest interventions are not products.

A meta-analysis of aerobic exercise reported improvements in erectile function from structured training, and a 2026 meta-analysis of lifestyle interventions found the same pattern across weight, diet, smoking and sleep. No botanical on any shelf has matched that evidence base.

That is not an argument against supplements. It is the context a reader needs before spending anything, because a man who buys a bottle instead of walking has made the worse of the two available decisions and a guide that does not say so is not a guide.

Vitamin D turns up on most labels in this aisle and it is the ingredient whose literature is strongest and whose relevance to vitality is weakest. Both halves of that sentence matter.

As a nutrient it is uncontroversial. It has an established role in calcium handling, bone, muscle function and immunity; it has a Daily Value, a dose response and an upper intake level of 4,000 IU a day for adults. A person who is short of it and stops being short of it has made a real change.

As a sex-hormone intervention it is thin. The 2026 meta-analysis of vitamin D and testosterone pooled the randomised evidence, and the trial in 307 men gave 1,400 IU a day after a loading dose for 150 days and found no overall change in sex steroids. A 2025 review of vitamin D and erectile function describes an association rather than a demonstrated effect.

Boron is a trace element with no established human requirement and a place on a great many vitality labels. Its reputation rests on a body of work small enough to describe in a paragraph.

A 1987 metabolic-unit study in twelve postmenopausal women at 3 mg a day started the interest. A 2011 study in eight healthy men gave 10 mg a day for a week and reported a rise in free testosterone with falls in sex hormone binding globulin and oestradiol. Eight men, seven days, no control group.

That is the study behind almost every boron row in this aisle. A review of boron in human nutrition and a 2026 review of boron as a dietary supplement cover the wider ground, which includes bone, magnesium handling and inflammatory markers and is more interesting than the hormone claim.

What makes boron unusual on these labels is that the researched amount is small enough for a supplement to carry. Ten milligrams is achievable, the adult upper intake level is 20 mg, and ordinary diets supply one to three milligrams from fruit, nuts and legumes. A label printing 7 mg is inside the range the research used, which is not something that can be said of most botanical rows in this category.

The dose column is what the published studies administered. It is the number to hold beside whatever a label prints.

Taking them in turn: the fenugreek trial and its libido companion are honest twelve-week studies at 600 mg, with a 2024 dose-ranging study going higher. The maca trial is the one that made its name and the systematic review is cautiously positive, both at gram doses. The positive tribulus trial used a standardised extract at 1,500 mg while an 800 mg arm did nothing, and a systematic review of the aphrodisiac claim did not support it.

Epimedium is the outlier. The enzyme measurement that made icariin interesting was a test-tube experiment, the follow-up work was cells and rats, and a 2022 review is candid about how little has followed. Epimedium material also varies widely between suppliers, so two labels printing one weight need not be selling one thing.

The notation 10:1 appears on thousands of labels and is the single most misread mark in the aisle. It describes a manufacturing step: ten parts of raw plant reduced to one part of finished extract.

The United States Pharmacopeia group's own paper on the subject says plainly that such ratios are descriptive, that no analytical method can verify one after the fact, and that they are nonetheless routinely used as though they were a measure of strength for dosage calculations.

Two consequences follow for a reader with a bottle in his hand. First, the multiplication is simple: 100 micrograms of a 10:1 extract works back to about a milligram of raw herb. Second, a ratio says nothing about whether the compounds that matter were concentrated, which is what standardisation to a named marker would tell you and what most labels in this category do not carry.

One fact about this category matters more than any individual label in it, and it is not printed on any of them.

An analysis of ten years of FDA adulteration warnings found sexual-enhancement products the largest single category of warnings, most often for undeclared sildenafil analogues. A review of how those analogues are detected describes how ordinary a spiked product looks until somebody assays it.

The reason this matters clinically rather than merely legally is the interaction between PDE5 inhibitors and nitrates, which can drop blood pressure dangerously. A man taking a nitrate for angina who swallows an unlabelled analogue has no way of knowing what he has taken.

Nothing in that paragraph is an accusation about any particular product. It is a base rate, and the sensible response to a base rate is to buy from a channel with a named lot, a telephone number and a refund desk rather than from an anonymous listing.

Two further category facts are worth carrying. A review asking whether testosterone boosters raise testosterone found the evidence base thinner than the marketing, and an analysis of what is actually in male performance supplements is a useful corrective to assumptions about what these bottles contain. A meta-analysis of herbal supplements in this space and a 2026 update both report modest effects where any exist.

A guide that never says this is not being useful. Some of what sends men to this aisle is better dealt with elsewhere, and recognising which is which costs nothing.

Erectile dysfunction is common and it is treatable, and its association with cardiovascular disease is strong enough that persistent difficulty is worth having assessed rather than managed privately with a bottle. MedlinePlus is a plain place to start reading about it.

Persistent fatigue has the same shape. Thyroid disease, iron deficiency, sleep apnoea and depression all present as low energy, all are diagnosable, and none of them responds to a botanical extract. The NIH complementary health centre's guidance on using supplements sensibly is worth ten minutes before any first purchase.

None of that makes a supplement a bad idea. It makes it a supplement: something taken alongside an accurate picture of what is going on, rather than instead of getting one.

The category's ingredient list is not fraudulent. Most of these names have some human research behind them and two of them have a great deal. What separates one bottle from another is almost never which names appear on the panel; it is the amounts beside them and whether the label lets you check.

The companion page turns that into seven checks with a pass or fail against each, and applies them to Horse Peak Gelatin, the product this website sells. It fails three of the seven. The scorecard is here.